@GoHome_Token Sleep is for the weak

eBioMedicine (part of “The Lancet Discovery Science”) published results from Intensity Therapeutics' Phase 1/2 IT-01 study of INT230-6 in metastatic or refractory cancers, showing a 75% disease control rate & 11.9-month median overall survival. Nasdaq: INTS

@GoHome_Token still refusing sleep like its a mission 😆

@GoHome_Token this hits way too close to home

@GoHome_Token

@GoHome_Token I feel the same way when the charts look spicy

@GoHome_Token $180 price of $GoHome #Event16

@GoHome_Token Im built for these late nights

@GoHome_Token

@GoHome_Token

business trip incoming✈️ Road Trip Preview presented by @MYPMSTORE

@GoHome_Token 🤣🤣

@GoHome_Token Relatable

@GoHome_Token True

@GoHome_Token bro said no sleep, just $GOHOME

@GoHome_Token 4am is the new 9pm

@GoHome_Token same vibes, no regrets 😇

@GoHome_Token Bro, this is too real… and kinda poetic

@GoHome_Token Grind now, nap later

@GoHome_Token Staying up for the culture

@GoHome_Token Nice

Need Pro Pricing? Shop our LED lighting and electrical supplies today!